期刊文献+

单病种临床路径与DRGs成本控制在ChiariⅠ畸形合并脊髓空洞症手术治疗中的应用研究 被引量:8

Practice and study in Clinical Pathway and DRGs medical cost control of surgical therapies for Chiari Ⅰ malformation complicated with syringomyelia
下载PDF
导出
摘要 目的:通过对ChiariⅠ畸形合并脊髓空洞症手术治疗临床路径与DRGs(Diagnosis Related Groups)成本控制绩效分析,评价单病种临床路径和DRGs医疗成本控制应用于临床管理的效果。方法:收集整理2005年10月至2006年9月脊髓空洞症科ChiariⅠ畸形合并脊髓空洞症手术治疗患者的信息,以其手术并发症发生率、平均住院天数、平均住院费用、患者满意率等作为评价指标,将实验组(应用临床路径和DRGs成本控制组)和对照组(未应用临床路径和DRGs成本控制组)进行对比分析。结果:应用临床路径和DRGs成本控制的患者与未应用这一方式的患者之间在手术并发症发生率、平均住院时间、平均住院费用、患者满意率方面有统计学显著差异。结论:单病种临床路径和DRGs成本控制模式应用于ChiariⅠ畸形合并脊髓空洞症手术治疗,可以明显促进CQI(Continuous Quality Improvement)、缩短平均住院时间,降低住院费用,提高患者满意率。 Objective:To evaluate the implementation effect of clinical pathway (CP) and DRGs cost control (CC) of surgical therapies for Chiari Ⅰ malformation complicated with syringomyelia patients. Methods:After consulting the information of the hospitalized patients after the surgical therapies from October 2005 to September 2006, we analyzed the effect of CP and CC using the average length of stay and the hospital charges for the patients as the evaluating indexes. Results:There was significant difference in CQI, the average length of stay, the hospital charges for the patients, and patient satisfaction between the CP-CC groups and the traditional groups. Conclusion: The method of clinical pathway and cost control can markedly improve medical quality and patient satisfaction, decrease the average length of stay and the hospital charges for surgical therapies for Chiari Ⅰ malformation complicated with syringomyelia patients.
机构地区 武警总医院
出处 《中国医院》 2007年第4期27-30,共4页 Chinese Hospitals
关键词 CHIARI Ⅰ畸形 脊髓空洞症 床路径 DRGS CQI Chiari Ⅰ, malformation, Syringomyelia, Clinical pathway, DRGs CQI
  • 相关文献

参考文献10

  • 1李旭东,郝秀兰.关于济宁医学院附属医院推行单病种最高限价的调查[J].中华医院管理杂志,2006,22(2):142-144. 被引量:26
  • 2靳清汉,王新利.我院实施单病种限价的实践[J].中国医院,2006,10(6):32-34. 被引量:8
  • 3Crummer MB,Carter V.Clinical Pathway-the Pavotal too[J].Cardiovase-Nurs,1993,7(4):30-34.
  • 4D'Amato L,Talmage L,Hyde K.Outcomes in abdominal hysterectomy patients with benign disease:use of physician developed clinical protocols[J].J Reprod Med.1998,43(11):975.
  • 5Wammack L,Mabrey J.Outcome assessment of total hip and total knee arthroplasty:critical pathways,variance analysis,and continuous quality improvement[J].Clin Nurs Spec,1998,12(3):122.
  • 6Leibman BD,Dillioglugil O,Abbas F.Impact of a clinical pathway for radical retropubic prostactectomy[J].Urology,1998,52(1):94.
  • 7Choong PF,Langford AK,Dowsey MM,et al.Clinical pathway for fractured neck of femur:a prospective,controlled study[J].Med J.2000,172(9):423.
  • 8Bailey D,Litaker D,Mion L.Developing better critical paths in healthcare:combining best practice and the quantitative approach[J].J Nurs Adm,1998,8(7/8):21.
  • 9Lawson M,Lapinski B,Velasco E.Tonsillectomy and adenoidectomy pathway plan of care for the pediatric patient in day surgery[J].J Perianesth Nurs,1997,12(6):387.
  • 10Goode C.Impact of a care map and case management on patient satisfaction and staff satisfaction,collaboration,and autonomy[J].Nurs Econ,1995,13(6):337.

二级参考文献7

共引文献28

同被引文献87

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部